Skip to main content
Top
Published in: Endocrine 3/2019

01-06-2019 | Insulins | Original Article

Elevated 1-h post-load plasma glucose is associated with right ventricular morphofunctional parameters in hypertensive patients

Authors: Angela Sciacqua, Maria Perticone, Sofia Miceli, Angelina Pinto, Velia Cassano, Elena Succurro, Francesco Andreozzi, Marta Letizia Hribal, Giorgio Sesti, Francesco Perticone

Published in: Endocrine | Issue 3/2019

Login to get access

Abstract

Purpose

Emerging data demonstrate that type 2 diabetes mellitus (T2DM) is associated with right ventricular (RV) dysfunction. A cutoff point of 155 mg/dL for the 1-hour (h) post-load plasma glucose, during oral glucose tolerance test (OGTT), identifies patients with normal glucose tolerance (NGT) at high risk to develop T2DM and cardiovascular (CV) disease. We investigated if 1-h post-load glucose may affect RV geometry and function in a group of never-treated hypertensive individuals.

Methods

We enrolled 446 Caucasian newly diagnosed hypertensive outpatients. All patients underwent an OGTT and a standard echocardiography. The tricuspid annular plane systolic excursion (TAPSE) and the RV fractional area change (RVFAC) were measured together with systolic pulmonary arterial pressure (s-PAP) and pulmonary vascular resistances (PVR). Insulin sensitivity was evaluated using the Matsuda index.

Results

Among all partecipants, 296 had NGT, 100 impaired glucose tolerance (IGT), and 50 T2DM. Considering the cutoff point of 155 mg/dl for 1-h glucose, NGT subjects were stratified into two groups: NGT < 155 (n = 207), NGT ≥ 155 (n = 89). Subjects NGT ≥ 155 presented a worse metabolic and inflammatory profile than NGT < 155. RV functional parameters (TAPSE, RVFAC, TAPSE/s-PAP, and TAPSE/PVR) were significantly reduced in NGT ≥ 155 subjects compared with NGT < 155 patients. On the contrary, s-PAP and PVR were significantly higher. At multiple regression analysis, 1-h glucose was the strongest predictor of TAPSE in NGT ≥ 155, IGT, and T2DM.

Conclusions

The presence of RV impairment in hypertensive NGT ≥ 155 subjects further complicates their CV burden and it may, at least in part, justify the worse clinical outcome in this setting of patients.
Literature
1.
go back to reference P. Gaede, P. Vedel, N. Larsen, G.V. Jensen, H.H. Parving, O. Pedersen, Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348(5), 383–393 (2003)CrossRefPubMed P. Gaede, P. Vedel, N. Larsen, G.V. Jensen, H.H. Parving, O. Pedersen, Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348(5), 383–393 (2003)CrossRefPubMed
2.
3.
go back to reference L. Zhou, W. Deng, L. Zhou, P. Fang, D. He, W. Zhang et al. Prevalence, incidence and risk factors of chronic heart failure in the type 2 diabetic population: systematic review. Curr. Diabetes Rev. 5(3), 71–84 (2009)CrossRef L. Zhou, W. Deng, L. Zhou, P. Fang, D. He, W. Zhang et al. Prevalence, incidence and risk factors of chronic heart failure in the type 2 diabetic population: systematic review. Curr. Diabetes Rev. 5(3), 71–84 (2009)CrossRef
4.
go back to reference A. Dei Cas, S.S. Khan, J. Butler, R.J. Mentz, R.O. Bonow, A. Avogaro et al. Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure. JACC Heart Fail. 3(2), 136–145 (2015)CrossRefPubMed A. Dei Cas, S.S. Khan, J. Butler, R.J. Mentz, R.O. Bonow, A. Avogaro et al. Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure. JACC Heart Fail. 3(2), 136–145 (2015)CrossRefPubMed
5.
6.
go back to reference R. Muniyappa, M. Montagnani, K.K. Koh, M.J. Quon, Cardiovascular actions of insulin. Endocr. Rev. 28(5), 463–491 (2007)CrossRefPubMed R. Muniyappa, M. Montagnani, K.K. Koh, M.J. Quon, Cardiovascular actions of insulin. Endocr. Rev. 28(5), 463–491 (2007)CrossRefPubMed
7.
go back to reference G. Frati, L. Schirone, I. Chimenti, D. Yee, G. Biondi-Zoccai, M. Volpe, An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. Cardiovasc. Res. 113(4), 378–388 (2017)CrossRefPubMed G. Frati, L. Schirone, I. Chimenti, D. Yee, G. Biondi-Zoccai, M. Volpe, An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. Cardiovasc. Res. 113(4), 378–388 (2017)CrossRefPubMed
8.
go back to reference S.R. Mittal, Right ventricular functions in patients with type 2 diabetes below 50 years. J. Assoc. Physicians India 55, 599–600 (2007)PubMed S.R. Mittal, Right ventricular functions in patients with type 2 diabetes below 50 years. J. Assoc. Physicians India 55, 599–600 (2007)PubMed
9.
go back to reference W. Kosmala, P. Colonna, M. Przewlocka-Kosmala, W. Mazurek, Right ventricular dysfunction in asymptomatic diabetic patients. Diabetes Care 27(11), 2736–2738 (2004)CrossRefPubMed W. Kosmala, P. Colonna, M. Przewlocka-Kosmala, W. Mazurek, Right ventricular dysfunction in asymptomatic diabetic patients. Diabetes Care 27(11), 2736–2738 (2004)CrossRefPubMed
10.
go back to reference W. Kosmala, M. Przewlocka-Kosmala, W. Mazurek, Subclinical right ventricular dysfunction in diabetes mellitus--an ultrasonic strain/strain rate study. Diabet. Med. 24(6), 656–663 (2007)CrossRefPubMed W. Kosmala, M. Przewlocka-Kosmala, W. Mazurek, Subclinical right ventricular dysfunction in diabetes mellitus--an ultrasonic strain/strain rate study. Diabet. Med. 24(6), 656–663 (2007)CrossRefPubMed
11.
go back to reference M.R. Movahed, N. Milne, Presence of biventricular dysfunction in patients with type II diabetes mellitus. Congest. Heart Fail. 13(2), 78–80 (2007)CrossRefPubMed M.R. Movahed, N. Milne, Presence of biventricular dysfunction in patients with type II diabetes mellitus. Congest. Heart Fail. 13(2), 78–80 (2007)CrossRefPubMed
12.
go back to reference R.L. Widya, R.W. van der Meer, J.W. Smit, L.J. Rijzewijk, M. Diamant, J.J. Bax, A. de Roos et al. Right ventricular involvement in diabetic cardiomyopathy. Diabetes Care 36(2), 457–462 (2013)CrossRefPubMedPubMedCentral R.L. Widya, R.W. van der Meer, J.W. Smit, L.J. Rijzewijk, M. Diamant, J.J. Bax, A. de Roos et al. Right ventricular involvement in diabetic cardiomyopathy. Diabetes Care 36(2), 457–462 (2013)CrossRefPubMedPubMedCentral
13.
go back to reference M.M. Tumuklu, U. Erkorkmaz, A. Ocal, The impact of hypertension and hypertension-related left ventricle hypertrophy on right ventricle function. Echocardiography 24(4), 374–384 (2007)CrossRefPubMed M.M. Tumuklu, U. Erkorkmaz, A. Ocal, The impact of hypertension and hypertension-related left ventricle hypertrophy on right ventricle function. Echocardiography 24(4), 374–384 (2007)CrossRefPubMed
14.
go back to reference S. Ghio, A. Gavazzi, C. Campana, C. Inserra, C. Klersy, R. Sebastiani, Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J. Am. Coll. Cardiol. 37(1), 183–188 (2001)CrossRefPubMed S. Ghio, A. Gavazzi, C. Campana, C. Inserra, C. Klersy, R. Sebastiani, Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J. Am. Coll. Cardiol. 37(1), 183–188 (2001)CrossRefPubMed
15.
go back to reference E.F. Aziz, M. Kukin, F. Javed, D. Musat, A. Nader, B. Pratap et al. Right ventricular dysfunction is a strong predictor of developing atrial fibrillation in acutely decompensated heart failure patients, ACAP-HF data analysis. J. Card. Fail. 16(10), 827–834 (2010)CrossRefPubMed E.F. Aziz, M. Kukin, F. Javed, D. Musat, A. Nader, B. Pratap et al. Right ventricular dysfunction is a strong predictor of developing atrial fibrillation in acutely decompensated heart failure patients, ACAP-HF data analysis. J. Card. Fail. 16(10), 827–834 (2010)CrossRefPubMed
16.
go back to reference J. West, K.D. Niswender, J.A. Johnson, M.E. Pugh, L. Gleaves, J.P. Fessel et al. A potential role for insulin resistance in experimental pulmonary hypertension. Eur. Respir. J. 41(4), 861–871 (2013)CrossRefPubMed J. West, K.D. Niswender, J.A. Johnson, M.E. Pugh, L. Gleaves, J.P. Fessel et al. A potential role for insulin resistance in experimental pulmonary hypertension. Eur. Respir. J. 41(4), 861–871 (2013)CrossRefPubMed
17.
go back to reference G. Hansmann, R.A. Wagner, S. Schellong, V.A. Perez, T. Urashima, L. Wang et al. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-γ activation. Circulation 115(10), 1275–1284 (2007)CrossRefPubMed G. Hansmann, R.A. Wagner, S. Schellong, V.A. Perez, T. Urashima, L. Wang et al. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-γ activation. Circulation 115(10), 1275–1284 (2007)CrossRefPubMed
18.
go back to reference L. Benson, E.L. Brittain, M.E. Pugh, E.D. Austin, K. Fox, L. Wheeler et al. Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension. Pulm. Circ. 4(2), 311–318 (2014)CrossRefPubMedPubMedCentral L. Benson, E.L. Brittain, M.E. Pugh, E.D. Austin, K. Fox, L. Wheeler et al. Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension. Pulm. Circ. 4(2), 311–318 (2014)CrossRefPubMedPubMedCentral
19.
go back to reference M.K. Rutter, H. Parise, E.J. Benjamin, D. Levy, M.G. Larson, J.B. Meigs et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 107(3), 448–454 (2003)CrossRefPubMed M.K. Rutter, H. Parise, E.J. Benjamin, D. Levy, M.G. Larson, J.B. Meigs et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 107(3), 448–454 (2003)CrossRefPubMed
20.
go back to reference R.M. Henry, O. Kamp, P.J. Kostense, A.M. Spijkerman, J.M. Dekker, R. van Eijck et al. Left ventricular mass increases with deteriorating glucose tolerance, especially in women: independence of increased arterial stiffness or decreased flow-mediated dilation: the Hoorn study. Diabetes Care 27(2), 522–529 (2004)CrossRefPubMed R.M. Henry, O. Kamp, P.J. Kostense, A.M. Spijkerman, J.M. Dekker, R. van Eijck et al. Left ventricular mass increases with deteriorating glucose tolerance, especially in women: independence of increased arterial stiffness or decreased flow-mediated dilation: the Hoorn study. Diabetes Care 27(2), 522–529 (2004)CrossRefPubMed
21.
go back to reference A. Ilercil, R.B. Devereux, M.J. Roman, M. Paranicas, M.J. O’grady, T.K. Welty et al. Relationship of impaired glucose tolerance to left ventricular structure and function: the Strong Heart Study. Am. Heart J. 141(6), 992–998 (2001)CrossRefPubMed A. Ilercil, R.B. Devereux, M.J. Roman, M. Paranicas, M.J. O’grady, T.K. Welty et al. Relationship of impaired glucose tolerance to left ventricular structure and function: the Strong Heart Study. Am. Heart J. 141(6), 992–998 (2001)CrossRefPubMed
22.
go back to reference M.A. Abdul-Ghani, T. Abdul-Ghani, N. Ali, R.A. Defronzo, One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 31(8), 1650–1655 (2008)CrossRefPubMedPubMedCentral M.A. Abdul-Ghani, T. Abdul-Ghani, N. Ali, R.A. Defronzo, One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 31(8), 1650–1655 (2008)CrossRefPubMedPubMedCentral
23.
go back to reference T.V. Fiorentino, M.A. Marini, F. Andreozzi, F. Arturi, E. Succurro, M. Perticone et al. One-Hour Post load Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose. J. Clin. Endocrinol. Metab. 100(10), 3744–3751 (2015)CrossRefPubMed T.V. Fiorentino, M.A. Marini, F. Andreozzi, F. Arturi, E. Succurro, M. Perticone et al. One-Hour Post load Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose. J. Clin. Endocrinol. Metab. 100(10), 3744–3751 (2015)CrossRefPubMed
24.
go back to reference G. Sesti, T.V. Fiorentino, E. Succurro, M. Perticone, F. Arturi, A. Sciacqua et al. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile. Acta Diabetol. 51(6), 927–932 (2014)CrossRefPubMed G. Sesti, T.V. Fiorentino, E. Succurro, M. Perticone, F. Arturi, A. Sciacqua et al. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile. Acta Diabetol. 51(6), 927–932 (2014)CrossRefPubMed
25.
go back to reference A. Sciacqua, R. Maio, S. Miceli, A. Pascale, G. Carullo, N. Grillo et al. Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension. PLoS ONE 7(9), e44470 (2012)CrossRefPubMedPubMedCentral A. Sciacqua, R. Maio, S. Miceli, A. Pascale, G. Carullo, N. Grillo et al. Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension. PLoS ONE 7(9), e44470 (2012)CrossRefPubMedPubMedCentral
26.
go back to reference E. Succurro, M.A. Marini, F. Arturi, A. Grembiale, M. Lugarà, F. Andreozzi et al. Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 207(1), 245–249 (2009)CrossRefPubMed E. Succurro, M.A. Marini, F. Arturi, A. Grembiale, M. Lugarà, F. Andreozzi et al. Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 207(1), 245–249 (2009)CrossRefPubMed
27.
go back to reference E. Succurro, F. Arturi, M. Lugarà, A. Grembiale, T.V. Fiorentino, V. Caruso et al. One-hour postload plasma glucose levels are associated with kidney dysfunction. Clin. J. Am. Soc. Nephrol. 5(11), 1922–1927 (2010)CrossRefPubMedPubMedCentral E. Succurro, F. Arturi, M. Lugarà, A. Grembiale, T.V. Fiorentino, V. Caruso et al. One-hour postload plasma glucose levels are associated with kidney dysfunction. Clin. J. Am. Soc. Nephrol. 5(11), 1922–1927 (2010)CrossRefPubMedPubMedCentral
28.
go back to reference A. Sciacqua, S. Miceli, G. Carullo, L. Greco, E. Succurro, F. Arturi et al. One-Hour Postload Plasma Glucose Levels and Left Ventricular Mass in Hypertensive Patients. Diabetes Care 34(6), 1406–1411 (2011)CrossRefPubMedPubMedCentral A. Sciacqua, S. Miceli, G. Carullo, L. Greco, E. Succurro, F. Arturi et al. One-Hour Postload Plasma Glucose Levels and Left Ventricular Mass in Hypertensive Patients. Diabetes Care 34(6), 1406–1411 (2011)CrossRefPubMedPubMedCentral
29.
go back to reference A. Sciacqua, S. Miceli, L. Greco, F. Arturi, P. Naccarato, D. Mazzaferro et al. One-hour postload plasma glucose levels and diastolic function in hypertensive patients. Diabetes Care 34(10), 2291–2296 (2011)CrossRefPubMedPubMedCentral A. Sciacqua, S. Miceli, L. Greco, F. Arturi, P. Naccarato, D. Mazzaferro et al. One-hour postload plasma glucose levels and diastolic function in hypertensive patients. Diabetes Care 34(10), 2291–2296 (2011)CrossRefPubMedPubMedCentral
30.
go back to reference ESH/ESC guidelines for the management of arterial hypertension, The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 34(28), 2159–2219 (2013)CrossRef ESH/ESC guidelines for the management of arterial hypertension, The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 34(28), 2159–2219 (2013)CrossRef
31.
go back to reference American Diabetes Association: Standards of medical care in diabetes–2017. Diabetes Care 40(Suppl. 1), S1–S135 (2017) American Diabetes Association: Standards of medical care in diabetes–2017. Diabetes Care 40(Suppl. 1), S1–S135 (2017)
32.
go back to reference M. Matsuda, R.A. DeFronzo, Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9), 1462–1470 (1999)CrossRefPubMed M. Matsuda, R.A. DeFronzo, Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9), 1462–1470 (1999)CrossRefPubMed
33.
go back to reference A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd, H.I. Feldman et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150(9), 604–612 (2009)CrossRefPubMedPubMedCentral A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd, H.I. Feldman et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150(9), 604–612 (2009)CrossRefPubMedPubMedCentral
34.
go back to reference R.M. Lang, L.P. Badano, V. Mor-Avi, J. Afilalo, A. Armstrong, L. Ernande et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 28(1), 1–39.e14 (2015)CrossRefPubMed R.M. Lang, L.P. Badano, V. Mor-Avi, J. Afilalo, A. Armstrong, L. Ernande et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 28(1), 1–39.e14 (2015)CrossRefPubMed
35.
go back to reference S.F. Nagueh, C.P. Appleton, T.C. Gillebert, P.N. Marino, J.K. Oh, O.A. Smiseth et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J. Am. Soc. Echocardiogr. 22(2), 107–133 (2009)CrossRefPubMed S.F. Nagueh, C.P. Appleton, T.C. Gillebert, P.N. Marino, J.K. Oh, O.A. Smiseth et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J. Am. Soc. Echocardiogr. 22(2), 107–133 (2009)CrossRefPubMed
36.
go back to reference L.G. Rudski, W.W. Lai, J. Afilalo, L. Hua, M.D. Handschumacher, K. Chandrasekaran et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 23(7), 685–713 (2010)CrossRefPubMed L.G. Rudski, W.W. Lai, J. Afilalo, L. Hua, M.D. Handschumacher, K. Chandrasekaran et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 23(7), 685–713 (2010)CrossRefPubMed
37.
go back to reference A.E. Abbas, F.D. Fortuin, N.B. Schiller, C.P. Appleton, C.A. Moreno, S.J. Lester, A simple method for non invasive estimation of pulmonary vascular resistance. J. Am. Coll. Cardiol. 41(6), 1021–1027 (2003)CrossRefPubMed A.E. Abbas, F.D. Fortuin, N.B. Schiller, C.P. Appleton, C.A. Moreno, S.J. Lester, A simple method for non invasive estimation of pulmonary vascular resistance. J. Am. Coll. Cardiol. 41(6), 1021–1027 (2003)CrossRefPubMed
38.
go back to reference M. Guazzi, F. Bandera, G. Pelissero, S. Castelvecchio, L. Menicanti, S. Ghio et al. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am. J. Physiol. Heart Circ. Physiol. 305(9), H1373–H1381 (2013)CrossRefPubMed M. Guazzi, F. Bandera, G. Pelissero, S. Castelvecchio, L. Menicanti, S. Ghio et al. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am. J. Physiol. Heart Circ. Physiol. 305(9), H1373–H1381 (2013)CrossRefPubMed
39.
go back to reference A. Lopez López-Candales, F.R. Lopez, S. Trivedi, J. Elwing, Right ventricular ejection efficiency: a new echocardiographic measure of mechanical performance in chronic pulmonary hypertension. Echocardiography 31(4), 516–523 (2014)CrossRefPubMed A. Lopez López-Candales, F.R. Lopez, S. Trivedi, J. Elwing, Right ventricular ejection efficiency: a new echocardiographic measure of mechanical performance in chronic pulmonary hypertension. Echocardiography 31(4), 516–523 (2014)CrossRefPubMed
40.
go back to reference T.V. Fiorentino, F. Sesti, F. Andreozzi, E. Pedace, A. Sciacqua, M.L. Hribal et al. One-hour post-load hyperglycemia combined with HbA1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden. Atherosclerosis 253, 61–69 (2016)CrossRefPubMed T.V. Fiorentino, F. Sesti, F. Andreozzi, E. Pedace, A. Sciacqua, M.L. Hribal et al. One-hour post-load hyperglycemia combined with HbA1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden. Atherosclerosis 253, 61–69 (2016)CrossRefPubMed
41.
go back to reference T.V. Fiorentino, E. Succurro, F. Andreozzi, A. Sciacqua, F. Perticone, G. Sesti, One-hour post-load hyperglycemia combined with HbA1c identifies individuals with higher risk of cardiovascular diseases: Cross-sectional data from the CATAMERI study. Diabetes Metab. Res. Rev. 30, e3096 (2018) T.V. Fiorentino, E. Succurro, F. Andreozzi, A. Sciacqua, F. Perticone, G. Sesti, One-hour post-load hyperglycemia combined with HbA1c identifies individuals with higher risk of cardiovascular diseases: Cross-sectional data from the CATAMERI study. Diabetes Metab. Res. Rev. 30, e3096 (2018)
42.
go back to reference M. Tadic, B. Ivanovic, I. Grozdic, Metabolic syndrome impacts the right ventricle: true or false? Echocardiography 28(5), 530–538 (2011)CrossRefPubMed M. Tadic, B. Ivanovic, I. Grozdic, Metabolic syndrome impacts the right ventricle: true or false? Echocardiography 28(5), 530–538 (2011)CrossRefPubMed
43.
go back to reference M. Tadic, B. Ivanovic, C. Cuspidi, Metabolic syndrome and right ventricle: an updated review. Eur. J. Intern. Med. 24(7), 608–616 (2013)CrossRefPubMed M. Tadic, B. Ivanovic, C. Cuspidi, Metabolic syndrome and right ventricle: an updated review. Eur. J. Intern. Med. 24(7), 608–616 (2013)CrossRefPubMed
44.
go back to reference V. Chavali, S.C. Tyagi, P.K. Mishra, Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab. Syndr. Obes. 6, 151–160 (2013)PubMedPubMedCentral V. Chavali, S.C. Tyagi, P.K. Mishra, Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab. Syndr. Obes. 6, 151–160 (2013)PubMedPubMedCentral
45.
go back to reference G. Sesti, A. Sciacqua, A. Scozzafava, M. Vatrano, E. Angotti, C. Ruberto et al. Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients. J. Hypertens. 25(2), 471–477 (2007)CrossRefPubMed G. Sesti, A. Sciacqua, A. Scozzafava, M. Vatrano, E. Angotti, C. Ruberto et al. Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients. J. Hypertens. 25(2), 471–477 (2007)CrossRefPubMed
46.
go back to reference O.L. Klein, J.A. Krishnan, S. Glick, L.J. Smith, Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabet. Med. 27(9), 977–987 (2010)CrossRefPubMed O.L. Klein, J.A. Krishnan, S. Glick, L.J. Smith, Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabet. Med. 27(9), 977–987 (2010)CrossRefPubMed
47.
go back to reference K. Sakata, H. Yoshino, H. Kurihara, K. Iwamori, H. Houshaku, A. Yanagisawa et al. Prognostic significance of persistent right ventricular dysfunction as assessed by radionuclide angiocardiography in patients with inferior wall acute myocardial infarction. Am. J. Cardiol. 85(8), 939–944 (2000)CrossRefPubMed K. Sakata, H. Yoshino, H. Kurihara, K. Iwamori, H. Houshaku, A. Yanagisawa et al. Prognostic significance of persistent right ventricular dysfunction as assessed by radionuclide angiocardiography in patients with inferior wall acute myocardial infarction. Am. J. Cardiol. 85(8), 939–944 (2000)CrossRefPubMed
48.
go back to reference M. Bergman, A. Chetrit, J. Roth, R. Dankner, One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel Study of Glucose Intolerance, Obesity and Hypertension. Diabet. Med. 33(8), 1060–1066 (2016)CrossRefPubMed M. Bergman, A. Chetrit, J. Roth, R. Dankner, One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel Study of Glucose Intolerance, Obesity and Hypertension. Diabet. Med. 33(8), 1060–1066 (2016)CrossRefPubMed
49.
go back to reference M. Bergman, M. Manco, G. Sesti, R. Dankner, M. Pareek, R. Jagannathan et al. Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose≥ 155 mg/dl (8.6 mmol/L). Diabetes Res. Clin. Pract. 146, 18–33 (2018)CrossRefPubMed M. Bergman, M. Manco, G. Sesti, R. Dankner, M. Pareek, R. Jagannathan et al. Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose≥ 155 mg/dl (8.6 mmol/L). Diabetes Res. Clin. Pract. 146, 18–33 (2018)CrossRefPubMed
Metadata
Title
Elevated 1-h post-load plasma glucose is associated with right ventricular morphofunctional parameters in hypertensive patients
Authors
Angela Sciacqua
Maria Perticone
Sofia Miceli
Angelina Pinto
Velia Cassano
Elena Succurro
Francesco Andreozzi
Marta Letizia Hribal
Giorgio Sesti
Francesco Perticone
Publication date
01-06-2019
Publisher
Springer US
Published in
Endocrine / Issue 3/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-01873-5

Other articles of this Issue 3/2019

Endocrine 3/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine